Psychomedycyna Spółka z Ograniczoną Odpowiedzialnością (KRS 0000656358, NIP 5423264737) is a Polish company, headquartered in Białystok, Podlaskie voivodeship. PSYCHOMEDYCYNA operates in: Other human health activities n.e.c. (PKD 86.90.E). Industry: Healthcare. The company has been listed in the National Court Register since December 30, 2016. PSYCHOMEDYCYNA's most recently reported net revenue was 233.5 K PLN for 2024.
Negative equity
Negative equity in 3 of 7 available reporting years.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Psychomedycyna
Identity
- Name
- Psychomedycyna Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- December 30, 2016
- Registry status as of
- June 26, 2026
- Latest entry
- June 26, 2026
- Founding act
- 19.12.2016 R. W KN TOMASZA POREDY W ŁOMŻY, REP. A NR 11913/2016 ZAWIĄZANO SPÓŁKĘ Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Articles of association history (1)
- December 19, 2016: 19.12.2016 R. W KN TOMASZA POREDY W ŁOMŻY, REP. A NR 11913/2016 ZAWIĄZANO SPÓŁKĘ Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Activities
Main activity
86.90.EOther human health activities n.e.c.
Other activities
Address and contact
- Address
- UL. FABRYCZNA, 4, 1B, 15-483, BIAŁYSTOK, POLSKA
- Voivodeship
- PODLASKIE
- District
- BIAŁYSTOK
- PSYCHOMEDYCYNA@INTERIA.PL
- Website
- Not disclosed in the registry
- E-delivery address
- AE:PL-26301-89974-HVCBH-19
Risk and payment profile - Psychomedycyna
Credibility rating
69.2 / 100
Good credibility
Insolvency risk
Very low
Low threat
Closure risk
1
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
0
0/9 yrs
Board changes
0
0/9 yrs
PKD changes
0
0/9 yrs
Name changes
0
0/9 yrs
Data from 9 years of registry activity.
Credibility history
Payment reliability score from 2018–2024
Current: C (69/100)
Trend: deteriorating (-5.6 pts/year)
Moderate payment credibility - the company is able to meet its obligations, but some indicators warrant caution.
Trade credit limit history
Standard limit from 2018–2024
Current: 49.5 K PLN
Safe: 22.3 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Psychomedycyna
Founded
December 30, 2016
9 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
BIAŁYSTOK
PODLASKIE
Primary PKD
86.90.E
Other human health activities n.e.c.
Share capital
5.0 K PLN
Shareholders
1
shareholder
Board
1 person
Filed years
7 years
2018–2024
Registry entries
24
latest: June 26, 2026
Risk signals
Revenue
233.5 K PLN
2024
Net profit
6.8 K PLN
2024
Assets
202.2 K PLN
2024
Equity
90.1 K PLN
2024
EBITDA
N/A
2024
no depreciation data
Valuation
70.7 K PLN
High confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Psychomedycyna.
No ratings
Related articles
News
Longevity Center launches Longevity Academy: Poland's first accredited longevity-medicine educational programme for doctors
Warsaw-based Longevity Center sp. z o.o. (KRS 0000796083, ul. Belwederska 9) has launched Longevity Academy - one of the first in the world and the first in Poland accredited longevity-medicine educational programme for doctors. Accreditation by the Polish Medical Chamber; scientific partner: the Buck Institute for Research on Aging in California. The programme is built on 6+ years of clinical practice and 3,000+ patients.
Explainer
Voxel in 2026: a Kraków operator of medical-imaging centres and radiopharmaceuticals, an mWIG40 issuer with a two-member management board
Voxel S.A. (KRS 0000238176), headquartered at ul. Wielicka 265 in Kraków, is a Polish operator of medical-imaging centre networks (MRI, CT, X-ray, ultrasound, mammography) and a radiopharmaceutical producer. The company was founded in 2005, listed on the WSE since 2011. It operates under the Voxel-Diagnostic brand at several dozen locations across Poland. A two-member management board, a five-member supervisory board.
